CBS 2019
CBSMD教育中心
中 文

急性冠脉综合征

Abstract

Recommended Article

Antiplatelet therapy in patients with myocardial infarction without obstructive coronary artery disease Myocardial Infarction Risk Stratification With a Single Measurement of High-Sensitivity Troponin I Epidemiology and Clinical Outcomes of Patients With Inflammatory Bowel Disease Presenting With Acute Coronary Syndrome Transition of Macrophages to Fibroblast-Like Cells in Healing Myocardial Infarction Morphine and Cardiovascular Outcomes Among Patients With Non-ST-Segment Elevation Acute Coronary Syndromes Undergoing Coronary Angiography Pharmacotherapy in the Management of Anxiety and Pain During Acute Coronary Syndromes and the Risk of Developing Symptoms of Posttraumatic Stress Disorder Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction Comparative Effectiveness of β-Blocker Use Beyond 3 Years After Myocardial Infarction and Long-Term Outcomes Among Elderly Patients

ConsensusVolume 72, Issue 18, October 2018

JOURNAL:J Am Coll Cardiol. Article Link

Fourth Universal Definition of Myocardial Infarction (2018)

Thygesen K, Alpert JS, Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction. Keywords: Cardiac procedural myocardial injury; Cardiac troponin; Expert Consensus Document; High sensitivity cardiac troponin; Myocardial infarction; Myocardial infarction with non-obstructive coronary arteries (MINOCA); Myocardial injury; Prior myocardial infarction; Re-infarction; Recurrent myocardial infarction; Silent myocardial infarction; Takotsubo syndrome; Type 1 MI; Type 2 MI; Type 3 MI; Type 4a MI; Type 4b MI; Type 4c MI; Type 5 MI

FULL TEXT PDF